腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02137 腾盛博药-B

未开盘 09-24 16:08:29

0.890

-0.005

-0.56%

最高0.890	最低0.850	成交量35.40万
今开0.865	昨收0.895	日振幅4.47%
总市值6.43亿	流通市值6.43亿	总股本7.22亿
成交额30.33万	换手率0.05%	流通股本7.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02137","market":"HK","secType":"STK","nameCN":"腾盛博药-B","latestPrice":0.89,"timestamp":1790237309560,"preClose":0.895,"halted":0,"volume":354000,"delay":0,"changeRate":-0.005586592178770954,"floatShares":722000000,"shares":722000000,"eps":-0.36017462720385235,"marketStatus":"未开盘","change":-0.005,"latestTime":"09-24 16:08:29","open":0.865,"high":0.89,"low":0.85,"amount":303342,"amplitude":0.044693,"askPrice":0.895,"askSize":22500,"bidPrice":0.89,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.28120638953287735,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790299800000},"marketStatusCode":0,"adr":0,"listingDate":1626105600000,"exchange":"SEHK","adjPreClose":0.895,"openAndCloseTimeList":[[1790213400000,1790222400000],[1790226000000,1790236800000]],"volumeRatio":0.7433851323129649,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02137","defaultTab":"news","newsList":[{"id":"1188227323","title":"创新药概念走高，云顶新耀、药明巨诺-B涨逾5%，金斯瑞生物科技涨逾4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188227323","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188227323?lang=zh_cn&edition=full","pubTime":"2026-09-23 11:01","pubTimestamp":1790132509,"startTime":"0","endTime":"0","summary":"9月23日，创新药概念走高，云顶新耀、药明巨诺-B涨逾5%，金斯瑞生物科技涨逾4%，康方生物、诺诚健华涨逾3%，基石药业涨逾2%，百济神州、药明生物、君实生物涨逾1%，信达生物跟涨。9月12-15日2026年世界肺癌大会召开，多项中国创新药临床数据集中亮相，康方生物依沃西单药OS数据、B7H3 ADC等成为焦点；与此同时，2026年国家医保目录谈判收官，商保创新药目录同步推进，支付端改革预期升温，\"出海商业化+支付改善\"的产业逻辑持续强化。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","02269","03347","02359","03759","06622","06978","06996","00241","09606","09688","09966","06606","09995","02137","06618","02268","01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141461","title":"克来机电：9月21日严立忠、曹卫红、李南增持股份合计101.23万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141461","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669141461?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:02","pubTimestamp":1790078523,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月22日市场公开信息、上市公司公告及交易所披露数据整理，克来机电最新董监高及相关人员股份变动情况：2026年9月21日公司高级管理人员严立忠、董事曹卫红、高级管理人员李南共增持公司股份101.23万股，占公司总股本为0.3861%。变动期间公司股价上涨7.24%，9月21日当日收盘报18.36元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200037128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0020","02137","BK1574","BK0130","BK0061","BK1161","603960","BK0251","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167351567","title":"腾盛博药生物科技有限公司因股份奖励归属增发285,375股，涉已发行股本变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1167351567","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167351567?lang=zh_cn&edition=full","pubTime":"2026-09-21 21:46","pubTimestamp":1789998382,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年9月21日发布公告，宣布已发行股本发生变动。本次变动源于根据该公司于2021年6月22日采纳的首次公开发售后股份奖励计划，向公司董事授出受限制股份单位并相应增发股份。本次增发285,375股普通股，占本次增发前公司已发行股本约0.0395%，每股发行价为0港元。完成后，公司已发行股本增至722,190,115股，库藏股维持13,053,500股，合计735,243,615股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药生物科技有限公司因股份奖励归属增发285,375股，涉已发行股本变动","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669693021","title":"腾盛博药-B(02137)因受限制股份单位获归属而发行28.54万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669693021","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669693021?lang=zh_cn&edition=full","pubTime":"2026-09-21 21:44","pubTimestamp":1789998285,"startTime":"0","endTime":"0","summary":"智通财经APP讯，腾盛博药-B(02137)发布公告，于2026年9月21日因根据公司于2021年6月22日采纳的首次公开发售后股份奖励计划授出的受限制股份单位归属，而向公司董事发行及配发28.54万股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1587","BK1161","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669163613","title":"克来机电：9月18日曹卫红、严立忠增持股份合计72万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669163613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669163613?lang=zh_cn&edition=full","pubTime":"2026-09-21 20:01","pubTimestamp":1789992111,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月21日市场公开信息、上市公司公告及交易所披露数据整理，克来机电最新董监高及相关人员股份变动情况：2026年9月18日公司董事曹卫红、高级管理人员严立忠共增持公司股份72.0万股，占公司总股本为0.2746%。变动期间公司股价上涨0.71%，9月18日当日收盘报17.12元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100028829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0020","603960","BK0130","BK1161","02137","BK1574","BK0251","BK0061","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140454541","title":"腾盛博药-B：9月18日回购3万股，耗资约2.58万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1140454541","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140454541?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:16","pubTimestamp":1789733797,"startTime":"0","endTime":"0","summary":"腾盛博药-B于2026年9月18日发布翌日披露报表。公告显示，公司当日于香港联交所场内回购普通股30,000股，约占回购前已发行股份总数的0.0042%。回购价格每股为0.86港元，合计支出25,800港元。公司购回授权于2026年6月16日获股东大会批准，总回购额度为72,185,205股，现已累计回购330,000股，剩余额度为72,185,205股减去330,000股。公司同时确认，本次回购符合香港联交所证券上市规则及其他相关法规。本公告由联席公司秘书李安康博士签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"腾盛博药-B：9月18日回购3万股，耗资约2.58万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668260923","title":"腾盛博药-B(02137)9月18日斥资2.58万港元回购3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668260923","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668260923?lang=zh_cn&edition=full","pubTime":"2026-09-18 20:12","pubTimestamp":1789733576,"startTime":"0","endTime":"0","summary":"智通财经APP讯，腾盛博药-B(02137)发布公告，于2026年9月18日，该公司斥资2.58万港元回购3万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","02137","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111390125","title":"腾盛博药-B2026年中期营收1,952.10万元，经调整净亏损9,606.40万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111390125","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111390125?lang=zh_cn&edition=full","pubTime":"2026-09-17 16:37","pubTimestamp":1789634248,"startTime":"0","endTime":"0","summary":"本季度信息\n财报显示，腾盛博药-B在2026年上半年录得营收约1,952.10万元，同比去年同期的2,812.70万元下降30.56%。同期，经调整净亏损为9,606.40万元，相比去年同期的14,658.70万元减少约34.47%，亏损幅度明显收窄。\n公司在成本端持续优化研发及管理支出。研发投入为9,833.20万元，相较去年同期的11,702.00万元下降15.97%，管理费用为5,257.60万元，同比减少9.70%。经营活动所用现金净流出为16,548.80万元，相比上年同期22,137.60万元减少25.24%，显示整体经营资金消耗进一步得到改善。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"腾盛博药-B2026年中期营收1,952.10万元，经调整净亏损9,606.40万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988061","title":"克来机电：9月15日高级管理人员严立忠、李南增持股份合计90万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988061","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667988061?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:01","pubTimestamp":1789560117,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月16日市场公开信息、上市公司公告及交易所披露数据整理，克来机电最新董监高及相关人员股份变动情况：2026年9月15日公司高级管理人员严立忠、高级管理人员李南共增持公司股份90.0万股，占公司总股本为0.3432%。变动期间公司股价上涨0.38%，9月15日当日收盘报15.71元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600033650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0020","BK1587","BK1161","BK0251","BK0061","603960","BK0130","02137","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123706774","title":"腾盛博药-B回购10万股股份，耗资约8.6万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1123706774","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123706774?lang=zh_cn&edition=full","pubTime":"2026-09-16 18:10","pubTimestamp":1789553443,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年9月16日公告披露，集团于香港联交所场内回购普通股10万股，占回购前已发行股本约0.0138%，每股回购价为0.86港元，总金额约8.6万港元。根据公告，腾盛博药-B的股份回购授权于2026年6月16日获股东大会通过，发行人可根据该授权合共回购72,185,205股，至今已在证券交易所根据授权合计回购300,000股，占回购授权获批时公司已发行股本的约0.0416%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药-B回购10万股股份，耗资约8.6万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667604012","title":"腾盛博药-B(02137)9月16日斥资8.6万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667604012","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667604012?lang=zh_cn&edition=full","pubTime":"2026-09-16 18:05","pubTimestamp":1789553141,"startTime":"0","endTime":"0","summary":"智通财经APP讯，腾盛博药-B(02137)发布公告，于2026年9月16日，该公司斥资8.6万港元回购10万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496907.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02137","BK1161","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154457483","title":"腾盛博药-B更新2026年8月股份变动月报表，股本小幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1154457483","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154457483?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:50","pubTimestamp":1788511833,"startTime":"0","endTime":"0","summary":"腾盛博药-B于2026年9月4日公布截至2026年8月31日的股份变动月报表。公告显示，公司法定/注册股本合计维持在1,200,000,000股普通股，面值为每股USD 0.000005，总额USD 6,000，与上月末保持一致。月报显示，截至7月底，公司已发行股份为721,978,947股，期末增加55,793股至722,034,740股；库存股份由12,723,500股增至12,923,500股，总股本由734,702,447股增至734,958,240股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663061720","title":"腾盛博药-B(02137.HK)8月31日斥资1.82万港元回购2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663061720","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663061720?lang=zh_cn&edition=full","pubTime":"2026-08-31 21:33","pubTimestamp":1788183206,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02137","BK1587","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176753745","title":"腾盛博药-B回购2万股股份，涉资约1.82万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176753745","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176753745?lang=zh_cn&edition=full","pubTime":"2026-08-31 21:28","pubTimestamp":1788182882,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年8月31日发布公告，披露当日公司在香港联交所进行股份回购。此次回购股份数量为20,000股，占该公司回购前已发行股本约0.0028%。本次回购价格每股介乎0.905港元至0.91港元之间，成交量加权平均价为0.9095港元，总耗资18,190港元。回购完成后，公司已发行股份总数保持在734,958,240股，其中包括722,034,740股在外流通股份及12,923,500股库藏股份。公司确认已遵守香港联交所上市规则及相关法律法规。本公告由联合公司秘书李安康博士签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药-B回购2万股股份，涉资约1.82万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663077159","title":"李安康减持腾盛博药-B(02137.HK)1500股 每股作价0.955港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077159","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663077159?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:10","pubTimestamp":1788174625,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1587","02137","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125209203","title":"腾盛博药-B回购12万股股份，耗资约12.09万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125209203","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125209203?lang=zh_cn&edition=full","pubTime":"2026-08-25 20:07","pubTimestamp":1787659655,"startTime":"0","endTime":"0","summary":"2026年8月25日，腾盛博药生物科技有限公司公告，当日于香港联交所场内回购普通股12万股，约占回购前已发行股本的0.0166%。本次回购价格区间为每股0.995港元至1.03港元，合计支付约120,937.50港元，折合约12.09万港元。回购完成后，公司已发行股本由原有的722,174,740股减少至722,054,740股；同时，库藏股增至12,903,500股。腾盛博药-B于2026年6月16日通过购回授权，可回购股份总数为72,185,205股，截至目前累计已回购180,000股，占授权决议获通过当日已发行股份数目的约0.0249%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药-B回购12万股股份，耗资约12.09万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661272579","title":"腾盛博药-B(02137)8月24日斥资6.03万港元回购6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661272579","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661272579?lang=zh_cn&edition=full","pubTime":"2026-08-24 22:32","pubTimestamp":1787581951,"startTime":"0","endTime":"0","summary":"智通财经APP讯，腾盛博药-B(02137)发布公告，于2026年8月24日，该公司斥资6.03万港元回购6万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1587","BK1161","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110406870","title":"腾盛博药-B于8月24日回购6万股并增发25.58万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1110406870","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110406870?lang=zh_cn&edition=full","pubTime":"2026-08-24 22:21","pubTimestamp":1787581315,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年8月24日公布翌日披露报表，宣布通过行使多项股份计划向员工发行新股，并在香港联交所场内回购部分股份，导致公司已发行股份总数和库藏股数量同时变动。此外，公司于2026年8月24日通过香港联交所场内回购60,000股普通股，占变动前已发行股本约0.0083%，每股回购价范围介乎0.995港元至1.01港元，合计耗资约6.03万港元。上述发行及回购完成后，公司已发行股本增至722,174,740股，库藏股数量增至12,783,500股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"腾盛博药-B于8月24日回购6万股并增发25.58万股","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661685251","title":"港股异动 | 腾盛博药-B(02137)涨超8% 中期公司拥有人应占亏损同比收窄32.08% 取得额外积极临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2661685251","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661685251?lang=zh_cn&edition=full","pubTime":"2026-08-21 11:33","pubTimestamp":1787283188,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，腾盛博药-B午前涨超8%，截至发稿，涨8.16%，报1.06港元，成交额5236.89万港元。消息面上，8月21日，腾盛博药-B发布截至2026年6月30日止6个月中期业绩，其他收入1950万元，同比减少30.6%；研发开支9830万元，同比减少16.0%；期内亏损1.01亿元，同比减少32.1%；公司拥有人应占亏损1.01亿元，同比收窄32.08%。于7月3日，公司亦公布其2b期ENRICH及 ENHANCE研究的治疗结束顶线数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","02137","BK4585","KCAI","BK4588","BK1161","VXUS","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661025810","title":"腾盛博药-B(02137.HK)：中期亏损为1.01亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661025810","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661025810?lang=zh_cn&edition=full","pubTime":"2026-08-21 07:27","pubTimestamp":1787268422,"startTime":"0","endTime":"0","summary":"格隆汇8月21日丨腾盛博药-B公布中期业绩，截至2026年6月30日止六个月，其他收入为人民币1950万元，同比减少30.6%。这主要是由于定期存款利率下降导致银行利息收入减少人民币790万元。期内亏损为人民币1.01亿元，与2025年同期的人民币1.49亿元相比，减少人民币4780万元或32.1%。亏损减少主要归因于其他收益增加以及运营开支减少。于7月3日，公司亦公布其2b期ENRICH及ENHANCE研究的治疗结束顶线数据。ENRICH及ENHANCE研究的详细数据预计将于2026年下半年公布。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260821/32341931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK1587","BK1574","02137"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.briibio.com","stockEarnings":[{"period":"1week","weight":0.0114},{"period":"1month","weight":-0.1359},{"period":"3month","weight":-0.0632},{"period":"6month","weight":-0.3643},{"period":"1year","weight":-0.5412},{"period":"ytd","weight":-0.3688}],"compareEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":-0.0294},{"period":"3month","weight":0.0922},{"period":"6month","weight":-0.0076},{"period":"1year","weight":-0.0663},{"period":"ytd","weight":-0.0339}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"腾盛博药生物科技有限公司是一家主要从事感染性疾病以及中枢神经系统疾病治疗方法开发的生物科技公司。该公司研发的产品主要包括乙型肝炎病（HBV）免疫治疗候选药物BRII-179、靶向乙型肝炎表面抗原（HBsAg）的研究性HBV中和单克隆抗体Tobevibart、以及用于治疗多重耐药性（MDR）和广泛耐药性（XDR）的革兰氏阴性菌感染的合成脂肽soralimixin（BRII-693）等。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.040695},{"month":2,"riseRate":0.6,"avgChangeRate":0.049398},{"month":3,"riseRate":0.2,"avgChangeRate":-0.163076},{"month":4,"riseRate":0.2,"avgChangeRate":-0.015797},{"month":5,"riseRate":0,"avgChangeRate":-0.081235},{"month":6,"riseRate":0.2,"avgChangeRate":-0.107834},{"month":7,"riseRate":0.8,"avgChangeRate":0.07356},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.000001},{"month":9,"riseRate":0.5,"avgChangeRate":-0.006726},{"month":10,"riseRate":0.2,"avgChangeRate":-0.127852},{"month":11,"riseRate":0.6,"avgChangeRate":0.286305},{"month":12,"riseRate":0.2,"avgChangeRate":-0.154392}],"exchange":"SEHK","name":"腾盛博药-B","nameEN":"BRII-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"腾盛博药-B,02137,腾盛博药-B股票,腾盛博药-B股票老虎,腾盛博药-B股票老虎国际,腾盛博药-B行情,腾盛博药-B股票行情,腾盛博药-B股价,腾盛博药-B股市,腾盛博药-B股票价格,腾盛博药-B股票交易,腾盛博药-B股票购买,腾盛博药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}